📦 NDC / package directory — not a drug information page
Lanadelumab-Flyo NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Lanadelumab-Flyo products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Looking for uses, warnings & side effects? Read our Lanadelumab-Flyo drug information page →Key stats
4
Package NDCs
6
Products
6
Active listings
0
Discontinued
2
Labelers
2
Strengths
2
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 6 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Lanadelumab-flyo 300 mg/2mL INJECTION, SOLUTION | 64538-0644-00 | — | On market | View → |
| TAKHZYRO lanadelumab-flyo 300 mg/2mL INJECTION, SOLUTION | 47783-0644-01 | — | Discontinued | View → |
| TAKHZYRO lanadelumab-flyo 150 mg/mL SOLUTION | 47783-0645-01 | — | On market | View → |
| TAKHZYRO lanadelumab-flyo 300 mg/2mL SOLUTION | 47783-0646-01 | — | On market | View → |
| TAKHZYRO lanadelumab-flyo 300 mg/2mL SOLUTION | 47783-0646-01 | — | On market | View → |
| TAKHZYRO lanadelumab-flyo 150 mg/mL SOLUTION | 47783-0645-01 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.